Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Sinonasal Carcinomas with Neuroendocrine Features: Histopathological Differentiation and Treatment Outcomes.

Soldatova L, Campbell RG, Carrau RL, Prevedello DM, Wakely P Jr, Otto BA, Filho LF.

J Neurol Surg B Skull Base. 2016 Dec;77(6):456-465. Epub 2016 Apr 26.

PMID:
27857871
2.

Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck.

Chau NG, Hurwitz S, Mitchell CM, Aserlind A, Grunfeld N, Kaplan L, Hsi P, Bauer DE, Lathan CS, Rodriguez-Galindo C, Tishler RB, Haddad RI, Sallan SE, Bradner JE, French CA.

Cancer. 2016 Dec 1;122(23):3632-3640. doi: 10.1002/cncr.30242. Epub 2016 Aug 10.

PMID:
27509377
3.

Role of Craniofacial Resection for Malignant Tumors Involving the Anterior Skull Base: Surgical Experience in a Single Institution.

Kim YS, Moon KS, Kim GW, Lim SC, Lee KH, Jang WY, Jung TY, Kim IY, Jung S.

Brain Tumor Res Treat. 2015 Oct;3(2):81-8. doi: 10.14791/btrt.2015.3.2.81. Epub 2015 Oct 30.

4.

Nodal metastasis and elective nodal level treatment in sinonasal small-cell and sinonasal undifferentiated carcinoma: a surveillance, epidemiology and end results analysis.

Ahn PH, Mitra N, Alonso-Basanta M, Adappa ND, Palmer JN, O'Malley BW Jr, Rassekh CH, Chalian A, Cohen RB, Lin A.

Br J Radiol. 2016;89(1058):20150488. doi: 10.1259/bjr.20150488. Epub 2015 Nov 11.

5.

Esthesioneuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma: differentiation in diagnosis and treatment.

Su SY, Bell D, Hanna EY.

Int Arch Otorhinolaryngol. 2014 Oct;18(Suppl 2):S149-56. doi: 10.1055/s-0034-1390014. Review.

6.

Incidence and survival patterns of sinonasal undifferentiated carcinoma in the United States.

Chambers KJ, Lehmann AE, Remenschneider A, Dedmon M, Meier J, Gray ST, Lin DT.

J Neurol Surg B Skull Base. 2015 Mar;76(2):94-100. doi: 10.1055/s-0034-1390016. Epub 2014 Sep 29.

7.

Survival in unresectable sinonasal undifferentiated carcinoma treated with concurrent intra-arterial cisplatin and radiation.

Noticewala SS, Mell LK, Olson SE, Read W.

World J Clin Cases. 2015 Feb 16;3(2):191-5. doi: 10.12998/wjcc.v3.i2.191.

8.

Intraoral mass presenting as maxillary sinus carcinoma: a case report.

Mahdavi O, Boostani N, Karimi S, Tabesh A.

J Dent (Tehran). 2013 Nov;10(6):562-8. Epub 2013 Nov 30.

9.

Combined-modality treatment improved outcome in sinonasal undifferentiated carcinoma: single-institutional experience of 21 patients and review of the literature.

Al-Mamgani A, van Rooij P, Mehilal R, Tans L, Levendag PC.

Eur Arch Otorhinolaryngol. 2013 Jan;270(1):293-9. doi: 10.1007/s00405-012-2008-5. Epub 2012 Apr 3. Review.

10.

Craniofacial Resection for Sinonasal Malignant Tumors: Statistical Analysis of Surgical Outcome over 17 Years at a Single Institution.

Mine S, Saeki N, Horiguchi K, Hanazawa T, Okamoto Y.

Skull Base. 2011 Jul;21(4):243-8. doi: 10.1055/s-0031-1280686.

11.

Treatment of malignant sinonasal tumours with intensity-modulated radiotherapy (IMRT) and carbon ion boost (C12).

Jensen AD, Nikoghosyan AV, Windemuth-Kieselbach C, Debus J, Münter MW.

BMC Cancer. 2011 May 22;11:190. doi: 10.1186/1471-2407-11-190.

12.

Carbon ion therapy for advanced sinonasal malignancies: feasibility and acute toxicity.

Jensen AD, Nikoghosyan AV, Ecker S, Ellerbrock M, Debus J, Münter MW.

Radiat Oncol. 2011 Apr 5;6:30. doi: 10.1186/1748-717X-6-30.

13.

Sinonasal undifferentiated carcinoma: a 13-year experience at a single institution.

Lin EM, Sparano A, Spalding A, Eisbruch A, Worden FP, Heth J, Sullivan SE, Thompson BG, Marentette LJ.

Skull Base. 2010 Mar;20(2):61-7. doi: 10.1055/s-0029-1236165.

Supplemental Content

Support Center